Similarly, in semaxanib (SU5416)/hypoxia (SuHx) model rats and PAH patients, perivascular macrophage infiltration increases and exhibits positive staining for FAO enzymes, whereas infiltration decreases after using the CPT1 inhibitor oxfenicine [87,133]. This evidence concerns the gene CPT1A and pulmonary arterial hypertension.